Atorvastatin Calcium
Pricing Report NDC 68084-564-01

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Atorvastatin Calcium (NDC 68084-564-01) is $0.12936 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Mar 18, 2015.

As a provided by American Health Packaging, this medication is distributed in a 10 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED in 1 BLISTER PACK (68084-564-11) configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.12936
Per EA

Effective Date
Mar 18, 2015
Billable Units
10 EA
Estimated Package Price
$1.29
Data Status
As of Apr 01, 2015
C/I - Chain or Independent Pharmacy
Package NDC
Description
10 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED in 1 BLISTER PACK (68084-564-11)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.11576 to $0.13508 per EA. Over this 1 year and 3 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.1158 - $0.1351
Market Volatility
16.69% Variance
Latest Trend
6.50%
Date Unit Price Unit Source Method Rate
Mar 18, 2015 $0.12936 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 18, 2015 $0.12147 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 21, 2015 $0.11872 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 17, 2014 $0.11773 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2014 $0.12118 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 22, 2014 $0.11576 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 17, 2014 $0.11593 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2014 $0.11896 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Aug 20, 2014 $0.11896 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 23, 2014 $0.12144 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jun 18, 2014 $0.11919 EAC/I - Chain or Independent PharmacyCode 1G - Generic
May 21, 2014 $0.12450 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Apr 23, 2014 $0.12319 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 19, 2014 $0.12419 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Feb 19, 2014 $0.12474 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jan 22, 2014 $0.12548 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Dec 18, 2013 $0.12791 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Nov 21, 2013 $0.13508 EAC/I - Chain or Independent PharmacyCode 1G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026